Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway

PLoS One. 2025 Feb 6;20(2):e0316798. doi: 10.1371/journal.pone.0316798. eCollection 2025.

Abstract

The nutraceutical COMP-4 -consisting of L-citrulline, ginger extract, and herbal components Paullinia cupana and muira puama-has been shown previously to stimulate the production of nitric oxide (NO) in a variety of tissue types. We hypothesized that COMP-4 may have a protective, stimulatory effect on the vascular endothelial cell. Human umbilical arterial endothelial cells were incubated for 24 hours with or without COMP-4 and, to replicate impairment of endothelial function, co-incubated with or without H2O2. NO intracellular content, nitrite formation and cGMP content in culture media, nitric oxide synthase (NOS) isoforms and mRNA content, pro-inflammatory cytokines, and PAI-1 expression and activity were measured. COMP-4 increased endothelial cell production of NO and cGMP and the expression of both endothelial NOS (eNOS) and inducible NOS (iNOS), in tandem with a reduction in cytokine expression and activity of PAI-1. Co-incubation of COMP-4 with H2O2 reversed detrimental effects of H2O2 on endothelial function, evidenced by improvement in NO availability and abrogation of the pro-inflammatory milieu. These results suggest that COMP-4 exerts a stimulatory effect on endothelial cell eNOS and iNOS to increase NO bioavailability, leading to a reduction in pro-inflammatory cytokines, particularly the prothrombotic PAI-1.

MeSH terms

  • Citrulline* / pharmacology
  • Cyclic GMP* / metabolism
  • Cytokines / metabolism
  • Dietary Supplements*
  • Endothelial Cells* / drug effects
  • Endothelial Cells* / metabolism
  • Endothelium, Vascular* / drug effects
  • Endothelium, Vascular* / metabolism
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Nitric Oxide Synthase Type II* / genetics
  • Nitric Oxide Synthase Type II* / metabolism
  • Nitric Oxide Synthase Type III* / genetics
  • Nitric Oxide Synthase Type III* / metabolism
  • Nitric Oxide* / metabolism
  • Plasminogen Activator Inhibitor 1 / genetics
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Signal Transduction* / drug effects

Substances

  • Nitric Oxide Synthase Type III
  • Nitric Oxide
  • Cyclic GMP
  • Nitric Oxide Synthase Type II
  • Hydrogen Peroxide
  • NOS3 protein, human
  • Citrulline
  • Plasminogen Activator Inhibitor 1
  • Cytokines
  • NOS2 protein, human